Bommareddy et al. demonstrated that combination of MEK inhibitor enhances antitumor effect of oncolytic herpes simplex virus against KRAS-mutant murine CRC tumors via enhancement of cytopathic activity and antitumor immunity [38]. This evidence concerns the gene MAP2K7 and colorectal carcinoma.